These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 30196533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H, Senthilselvan A, Salopek TG.
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [Abstract] [Full Text] [Related]

  • 4. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [Abstract] [Full Text] [Related]

  • 5. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ, Grotz TE, Comfere NI, Inselman JW, Habermann EB.
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [Abstract] [Full Text] [Related]

  • 6. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ, Ko J, Damiani G, Funchain P, Knackstedt T, Vij A, Vidimos A, Gastman BR.
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [Abstract] [Full Text] [Related]

  • 7. A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas.
    Cooper C, Wayne JD, Damstetter EM, Martini M, Gordon J, Guitart J, West DP, Nardone B, Rademaker A, Gerami P.
    J Am Acad Dermatol; 2013 Nov; 69(5):693-699. PubMed ID: 23978604
    [Abstract] [Full Text] [Related]

  • 8. Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.
    Mitteldorf C, Bertsch HP, Jung K, Thoms KM, Schön MP, Tronnier M, Kretschmer L.
    Ann Surg Oncol; 2014 Jul; 21(7):2252-8. PubMed ID: 24652352
    [Abstract] [Full Text] [Related]

  • 9. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition American Joint Committee on Cancer Staging System?
    Egger ME, Stevenson M, Bhutiani N, Jordan AC, Scoggins CR, Philips P, Martin RC, McMasters KM.
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [Abstract] [Full Text] [Related]

  • 10. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C, Lyon M, Torphy RJ, Thieu D, Hosokawa P, Gonzalez R, Lewis KD, Medina TM, Rioth MJ, Robinson WA, Kounalakis N, McCarter MD, Gleisner AL.
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
    Winder AA, Boyer Z, Ch'ng S, Stretch JR, Saw RPM, Shannon KF, Pennington TE, Nieweg OE, Varey AHR, Scolyer RA, Thompson JF, Cust AE, Lo SN, Spillane AJ, Smith AL.
    Ann Surg Oncol; 2024 Aug; 31(8):5331-5339. PubMed ID: 38802717
    [Abstract] [Full Text] [Related]

  • 13. Is mitotic rate still useful in the management of patients with thin melanoma?
    Tejera-Vaquerizo A, Pérez-Cabello G, Marínez-Leborans L, Gallego E, Oliver-Martínez V, Martín-Cuevas P, Arias-Santiago S, Aneiros-Fernández J, Herrera-Acosta E, Traves V, Herrera-Ceballos E, Nagore E.
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2025-2029. PubMed ID: 28750139
    [Abstract] [Full Text] [Related]

  • 14. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ, Bastiaannet E, Sloot S, Suurmeijer AJ, Hoekstra HJ.
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH.
    Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
    [Abstract] [Full Text] [Related]

  • 17. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
    Tejera-Vaquerizo A, Ribero S, Puig S, Boada A, Paradela S, Moreno-Ramírez D, Cañueto J, de Unamuno B, Brinca A, Descalzo-Gallego MA, Osella-Abate S, Cassoni P, Carrera C, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Orland A, Jaka A, Fernández-Figueres MT, Hilari JM, Giménez-Xavier P, Vieira R, Botella-Estrada R, Román-Curto C, Ferrándiz L, Iglesias-Pena N, Ferrándiz C, Malvehy J, Quaglino P, Nagore E, SENTIMEL group.
    Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
    [Abstract] [Full Text] [Related]

  • 18. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
    Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL, Karakousis GC.
    Ann Surg Oncol; 2014 Feb; 21(2):643-9. PubMed ID: 24121883
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.
    Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM.
    Ann Surg Oncol; 2004 Mar; 11(3):247-58. PubMed ID: 14993019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.